Slices of Pharma Pie
Monday, May 26th, 2008Cardinal Health (healthcare) $47.9 Billion
Merck (pharmaceuticals) $47.7 Billion
Pfizer (pharmaceuticals) $32.3 Billion
Glaxo Smith Kline (pharmaceuticals) $29.5 Billion
Bayer (pharmaceuticals) $27.1 Billion
United Health Group (healthcare) $23.4 Billion
Bristol-Myers Squibb (pharmaceuticals) $21.7 Billion
Pharmacia (pharmaceuticals) $19.3 Billion
Novartis (pharmaceuticals) $18.9 Billion
Amerisource Bergen (healthcare) $15.8 Billion
WellPoint Health Networks (healthcare) $12.4 Billion
Source: Forbes 500, 2002 Revenue
I came across this short piece of information [...]
MS - name ambiguity
Thursday, May 15th, 2008If you visit the most popular Multiple Sclerosis related web site of National Multiple Sclerosis Society (USA), you will be presented with this so seemingly elegant MS description:
Multiple sclerosis (or MS) is a chronic, often disabling disease that attacks the central nervous system (CNS), which is made up of the brain, [...]
Why MS will never be treated
Tuesday, May 6th, 2008Want a proof?
1. Look what is explaining us MS treatment related report “Commercial Insight: Multiple Sclerosis Continued growth makes the MS market a highly attractive investment”:
This report focuses on the leading disease-modifying therapies used to treat MS, with seven major market (7MM) sales and volume forecasts to 2016
Assessment of current and future [...]
MS cures - simple thoughts
Monday, May 5th, 2008Disease never comes without a cause
The way is prepared, and disease invited, by disregard of the laws of health
For the first 5000 years of civilization, humans relied on foods and herbs for medicine. Only in the past 50 years or so have we forgotten our medicinal “roots” in favor of patent medicines. [...]
Who’s business is your MS?
Tuesday, February 19th, 2008What happened after you were diagnosed with Multiple Sclerosis?
Most probably your neurologist briefly explained your situation, available treatment etc. But were you questioned in the following (or similar) manner:
Were you asked at least one question concerning your lifestyle, nutrition patterns, habits, living and work related conditions?
Has he/she asked you about other health [...]
On “MS and Dealing with False Advertisement of CURES”
Wednesday, February 13th, 2008I am interested in everything MS related.
I must. As I was diagnosed with MS (at least de-myelination in my brain) in 1996.
More about my MS in a separate article MS cures story.
As I have no any MS symptoms, I myself am not interested in any MS cures. Furthermore, I know enough about [...]
Orthodox MS symptoms treatment
Tuesday, November 20th, 2007Orthodox medicine presently is using two drugs groups to possibly reduce MS symptoms:
corticosteroids (prednisone, methylprednisone, …)
multiple sclerosis immunemodulatory drugs
Orthodox medicine, driven by very powerful multi-billion pharmaceutical industry, proposes some medicines for some multiple sclerosis symptoms treatment. Today’s reality - every drug available in medicine today carries a risk [...]
News from MS market ‘07
Friday, November 16th, 2007The dynamic MS market continues to grow unabated; seven major market revenues increased 14.7% from 2005 to $4.6 billion in 2006. Growth is driven by the highly successful beta-interferon brands, Teva’s Copaxone (glatiramer acetate), and the recent relaunch of Tysabri; the first launch of a new MS treatment for six years [...]
MS Treatment Market will Reach $11.9 Billion by 2011
Saturday, November 10th, 2007NewswireToday - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report showing the growth of MS treatments from $4.4 billion in 2004 to nearly $5.9 billion in 2006
“Multiple Sclerosis: Worldwide Market Outlook to 2011” predicts a growth of $6 million by 2011. The report [...]